A research team led by Prof. Cao Xiaofeng from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences has uncovered a key translational regulatory mechanism ...

You can reach Isabella on Signal at isabellacueto.03. WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming a political re ...

President Donald Trump's Department of Health and Human Services (HHS) is terminating awards totaling more than $750 million dollars that were provided to pharmaceutical manufacturer Moderna to ...

Moderna is down 33.4% since the beginning of the year, and at $27.99 per share, it is trading 83.2% below its 52-week high of $166.61 from May 2024. Investors who bought $1,000 worth of Moderna ...

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...

Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation ...

But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu vaccine, claiming that “mRNA technology remains under-tested ...

MRNA Q1 2025 profit falls 21% to SAR 4.2M 3 M 2025 MRNA’s 2024 profit down 17% to SAR 30.4M; Q4 at SAR 10.4M 12 M 2024 MRNA profit slides 50% to SAR 20M in 9M 2024; Q3 at SAR 8.2M 9 M 2024 MRNA H1 ...

The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test and license mRNA-based vaccines to ...